Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Japanese Drug Makers Are Innovative But Regulations Are a Problem: Prof.Kneller at JPLA Seminar
March 10, 2003
- Detailed Rules for CRC Certification Announced by JSCPT
March 10, 2003
- PHARMA NETWORK Codevelops MR Evaluation System
March 10, 2003
- Korosho to Use Electronized Data to Optimize Nursing Care Benefits
March 10, 2003
- BUSINESS NEWS IN BRIEF
March 10, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 10, 2003
- WEBSITE NEWS
March 10, 2003
- Fujisawa Updates R&D Pipeline
March 10, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
March 10, 2003
- PRESS SEMINAR
March 10, 2003
- Gov't Allows Private Companies to Operate Medical Institutions
March 10, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 10, 2003
- Schedule for Changes in Approval Procedures Outlined
March 10, 2003
- Toyama Transfers OTC Products to Taisho, Kyorin
March 10, 2003
- PFSB Taking Public Comments on Amended PAL Ordinances
March 10, 2003
- JACDS Drafting GLs for Introduction of Category Management
March 10, 2003
- JMA to Stress Need for Higher Price Adjustment Zone
March 10, 2003
- OTC NEWS IN BRIEF
March 10, 2003
- Package Insert Revisions for Edaravone Required: Safety Info
March 10, 2003
- DIAGNOSTIC NEWS IN BRIEF
March 10, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…